Retrograde Technique: High Success Rate in CTO

Original Title: Outcomes With the Use of the Retrograde Approach for Coronary Chronic Total Occlusion Interventions in a Contemporary Multicenter US Registry.

Reference: Dimitri Karmpaliotis et al. Circ Cardiovasc Interv. 2016 Jun;9(6).

 

Retrograde Technique CTOThis study evaluated the safety and efficacy of the retrograde technique for chronic total occlusions. Researchers compared retrograde vs. anterograde technique outcomes in 1,301 procedures from 11 experienced centers across the US between the years 2012 and 2015.

Population mean age was 65.5±10 years with high diabetes prevalence (45%) and prior MI revascularization surgery (34%).

Globally, technical success was 90%, which reflects the experience of these centers, and major cardiovascular adverse events rate was 2.4%.

The retrograde technique was used in 539 cases (41%), both as initial strategy (46%) and after a failed anterograde attempt (54%).

Comparing both techniques, the retrograde technique was used in more complex cases, both from the clinical (prior surgery 48% vs. 24%; p<0.001) and angiographic point of views (mean Japan CTO score 3.1±1.0 vs 2.1±1.2; p<0.001) and resulted in lower technical success (85% vs. 94%; p<0.001) and higher complications rate (4.3% vs 1.1%; p<0.001).

Multivariable analyzis showed that the presence of suitable collaterals, no prior CABG and the left anterior descending artery as target vessel were success predictors for the retrograde technique.

Conclusion

The retrograde approach is commonly used in the daily contemporary practice especially on most challenging lesions and patients. Despite lower success and higher complications rates compared to the anterograde technique, it is an essential tool to maintain high success rates in chronic total occlusions.

 

We value your opinion. You are more than welcome to leave your comments, thoughts, questions or suggestions here below.

More articles by this author

AHA 2024 | SUMMIT

It has been previously shown that the pharmacological treatment of obesity (semaglutide) can reduce cardiovascular events in patients with cardiac failure (CF) and preserved...

AHA 2024 – BPROAD

Hypertension (elevated blood pressure, BP) is the most common comorbidity among diabetic patients and has been associated with higher cardiovascular risk, though as a...

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies have already shown commissure alignment facilitates post...

TRISCEND II: Transcatheter Replacement vs. Medical Treatment for Tricuspid Regurgitation

The EVOQUE device is designed with an intra-annular sealing system that provides excellent anatomical compatibility and an adaptable shape. It is currently available in...